News & Updates

Folic acid treatment may halt disease progression in mild-to-moderate CKD

28 Mar 2020

Patients with mild-to-moderate chronic kidney disease (CKD) may benefit from folic acid treatment, which helps reduce the likelihood of CKD progression, especially among those with high vitamin B12 levels, as shown in a study.

Folic acid treatment may halt disease progression in mild-to-moderate CKD

28 Mar 2020

Asciminib shows therapeutic potential in chronic myeloid leukaemia

28 Mar 2020

The allosteric inhibitor asciminib shows clinical activity in heavily pretreated patients with chronic myeloid leukaemia who have failed or cannot tolerate tyrosine kinase inhibitors, including those who do not respond to ponatinib and harbour a T315I mutation, according to the results of a phase I dose-escalation study.

Asciminib shows therapeutic potential in chronic myeloid leukaemia

28 Mar 2020

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

28 Mar 2020

Both acarbose and repaglinide are effective for the control of postprandial hyperglycaemia in type 2 diabetes patients, a new study has found.

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

28 Mar 2020

Every-2-month cabotegravir + rilpivirine feasible for HIV treatment

27 Mar 2020 by

Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.

Every-2-month cabotegravir + rilpivirine feasible for HIV treatment

27 Mar 2020

$Add-on IW-3718 relieves heartburn symptoms in refractory GERD$

Add-on IW-3718 relieves heartburn symptoms in refractory GERD

27 Mar 2020

Use of the bile acid sequestrant IW-3718 as an adjunct to proton pump inhibitor (PPI) therapy is well tolerated and reduces heartburn and regurgitation symptoms in patients with refractory gastro-oesophageal reflux disease (GERD), according to the results of a trial.

Add-on IW-3718 relieves heartburn symptoms in refractory GERD

27 Mar 2020

Dual trumps triple therapy in reducing bleeding risk in AF patients after PCI

27 Mar 2020

Treatment with direct oral anticoagulant (DOAC) plus P2Y12 inhibitor (dual therapy) in adults with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) reduces bleeding risk compared with vitamin K antagonist plus aspirin and P2Y12 inhibitor (triple therapy), suggest a study.

Dual trumps triple therapy in reducing bleeding risk in AF patients after PCI

27 Mar 2020

Cannabinoids, SSRIs ineffective against cannabis use disorder

27 Mar 2020

Several pharmacologic interventions, including cannabinoids and selective serotonin reuptake inhibitors (SSRIs), do not appear to be effective in the treatment of cannabis use disorder (CUD), a study has shown.

Cannabinoids, SSRIs ineffective against cannabis use disorder

27 Mar 2020

Losartan does not reduce inflammation, fibrosis in HIV patients

27 Mar 2020 by

The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.

Losartan does not reduce inflammation, fibrosis in HIV patients

27 Mar 2020

MOXI trial: Antioxidants treatment for male infertility proves fruitless

27 Mar 2020 by

Use of antioxidants for treating male factor infertility appears to be of little benefit, improving neither semen parameters nor DNA integrity, according to the results of the Males, Antioxidants and Infertility (MOXI) trial.

MOXI trial: Antioxidants treatment for male infertility proves fruitless

27 Mar 2020

$Aspirin potentially protective against fracture$

Aspirin potentially protective against fracture

27 Mar 2020

Aspirin use in adults results in lower fracture risk and higher bone mass density (BMD) at the spine and the hip, according to the results of a meta-analysis.

Aspirin potentially protective against fracture

27 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Folic acid treatment may halt disease progression in mild-to-moderate CKD

Folic acid treatment may halt disease progression in mild-to-moderate CKD

Asciminib shows therapeutic potential in chronic myeloid leukaemia

Asciminib shows therapeutic potential in chronic myeloid leukaemia

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

Repaglinide, acarbose effective for postprandial glycaemic control in type 2 diabetes

Every-2-month cabotegravir + rilpivirine feasible for HIV treatment

Every-2-month cabotegravir + rilpivirine feasible for HIV treatment

Add-on IW-3718 relieves heartburn symptoms in refractory GERD

Add-on IW-3718 relieves heartburn symptoms in refractory GERD

Dual trumps triple therapy in reducing bleeding risk in AF patients after PCI

Dual trumps triple therapy in reducing bleeding risk in AF patients after PCI

Cannabinoids, SSRIs ineffective against cannabis use disorder

Cannabinoids, SSRIs ineffective against cannabis use disorder

Losartan does not reduce inflammation, fibrosis in HIV patients

Losartan does not reduce inflammation, fibrosis in HIV patients

MOXI trial: Antioxidants treatment for male infertility proves fruitless

MOXI trial: Antioxidants treatment for male infertility proves fruitless

Aspirin potentially protective against fracture

Aspirin potentially protective against fracture